The Continued Rise Of Immune Checkpoint Inhibitors, CAR T-Cell Therapy & KRAS Inhibitors: These Are the Top Cancer Treatment Advancements of 2021

Published Jan 5, 2022

The Continued Rise Of Immune Checkpoint Inhibitors, CAR T-Cell Therapy & KRAS Inhibitors: These Are the Top Cancer Treatment Advancements of 2021

NOW
PLAYING
What Are the Treatment Options for a Multiple Myeloma Patient Who Experiences Their First Relapse?
NOW
PLAYING
How Do Doctors Determine Which Multiple Myeloma Patients Receive CAR T-Cell Therapy?
NOW
PLAYING
Transplant After Induction for Multiple Myeloma: Is it Controversial?
NOW
PLAYING
Multiple Myeloma: The Future of CAR T-Cell Therapy & Other Treatments
NOW
PLAYING
How Does CAR T-Cell Therapy Work for Multiple Myeloma and When is it Used?
NOW
PLAYING
CAR T-Cell Therapy: A Promising New Approach to Relapsed Multiple Myeloma

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.